EUVIMEDEUVIMED entdecken
Crossref

Potassium-Competitive Acid Blocker (P-CAB) Generasi Baru: Studi Farmakologi dan Klinis Vonoprazan Fumarate

Ade Rezki Ilahi, Ellin Febrina

JFL : Jurnal Farmasi Lampung · 2025

DOI: 10.37090/hf4n3x55 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JFL : Jurnal Farmasi Lampung, 2025. Verfasst von Ade Rezki Ilahi und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to determine the pharmacological profile, clinical effectiveness, and safety of Vocinti (vonoprazan fumarate) as a P-CAB class gastric acid secretion inhibitor therapy. The method used was a literature review with a qualitative-descriptive approach. Information was collected, manually sorted and critically reviewed to ensure its validity and relevance, in order to produce a comprehensive picture of the pharmacological aspects, clinical effectiveness, and safety of Vocinti use. Based on the available literature review, Vocinti (vonoprazan fumarate) as a P-CAB class gastric acid secretion inhibitor therapy shows a superior pharmacological profile compared to conventional PPIs. Vonoprazan works through reversible competitive inhibition of the H+/K+-ATPase enzyme, resulting in faster, stronger, and more consistent acid suppression, with a longer duration of action and independence from acid activation. Thus, vonoprazan is worthy of consideration as an alternative primary therapy for gastric acid disorders, especially in refractory patients or those requiring long-term therapy. Keywords: P-CAB, Vonoprazan Fumarate Clinical, Pharmacological Studies, Vocinti

Zitieren

APA

Ilahi, A. R., & Febrina, E. (2025). Potassium-Competitive Acid Blocker (P-CAB) Generasi Baru: Studi Farmakologi dan Klinis Vonoprazan Fumarate. JFL : Jurnal Farmasi Lampung. https://doi.org/10.37090/hf4n3x55

Vancouver

Ilahi AR, Febrina E. Potassium-Competitive Acid Blocker (P-CAB) Generasi Baru: Studi Farmakologi dan Klinis Vonoprazan Fumarate. JFL : Jurnal Farmasi Lampung. 2025. doi:10.37090/hf4n3x55

BibTeX
@article{Ilahi2025,
  author = {Ilahi, Ade Rezki and Febrina, Ellin},
  title = {Potassium-Competitive Acid Blocker (P-CAB) Generasi Baru: Studi Farmakologi dan Klinis Vonoprazan Fumarate},
  journal = {JFL : Jurnal Farmasi Lampung},
  year = {2025},
  doi = {10.37090/hf4n3x55}
}
Kostenlos starten →